Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Look At The Facts They Speak Volumes
View:
Post by Walter333 on Feb 16, 2022 11:51am

Look At The Facts They Speak Volumes

Look at the facts, past performance history, and all filings over the years.
Comment by DavidRosenberg on Feb 16, 2022 11:54am
show me a biotech company with no debt on the balance sheet and with 40,000,000 USD in the bank that has 3 molecules pending the start of clinical trials that have strong IP and that nobody else has  you can't find much FSD is undervalued in my opinion that's why i averaged down last time all stocks carrry risks and im not a professional so dont take my word as advvice to buy sell ...more  
Comment by Mil_Man54 on Feb 16, 2022 12:41pm
Rosenberg....show me a successful company who in their history that has 2 failed endeavours....that was successfully sued for purposely misleading investors....produced no revenue for 3 years....performed the largest RS in CSE history....is unable to unload a major facilty....and using share dilution as their go to for financing pet projects....
Comment by DavidRosenberg on Feb 16, 2022 1:54pm
Biotechs at this stage dont need revenues Biotech Valuation Best Practices | Toptal Why Biotech Pipeline Valuation Is Different Biotech firms are not your standard widget manufacturer that you learned to value in your MBA and/or CFA courses. Read on to understand some of the unique traits specific to the industry. What Revenues? As we’ve already noted, many biotech firms do not yet ...more  
Comment by Mil_Man54 on Feb 16, 2022 3:30pm
Kinda glossed over everything else.. eh Rosenberg....what...couldn't find an article saying it's OK to mislead investors and get successfully sued...or one that says an RS of 201:1 is a good thing....how about one that says dilution of shares as a primary and ongoing source of funding is a solid business strategy....or how about one that says 2 failed ventures and a continued strategy of ...more  
Comment by Walter333 on Feb 16, 2022 1:44pm
INCYTE - 1.6 billion cash 3x current liabilities REGENERON - 7.9 billion current assets if which 3.1 is cash 2x current liabilities VERTEX - no debt 5.5 billion cash 3x current liabilities. Get off of the soap box and sit down junior. 40 mil in grifted funds from previous failed endeavours is peanuts, chump change. FSD is a minnow in the ocean.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities